Form 4: ClearPoint Neuro Director Linda M. Liau Acquires Shares in Lieu of Fees

Director Linda M. Liau acquired 550 shares of ClearPoint Neuro, Inc. common stock on July 1, 2024, as payment for director fees.

Summary

• On July 1, 2024, Linda M. Liau, a director of ClearPoint Neuro, Inc., acquired 550 shares of common stock.
• The acquisition was made through the company's Fifth Amended and Restated 2013 Incentive Compensation Plan.
• The shares were issued in payment of fees owed to Liau under the Non-Employee Director Compensation Plan, as amended and restated.
• The price per share was $5.39, based on the closing price of ClearPoint Neuro's common stock on June 28, 2024.
• Following the transaction, Liau directly owns 30,834 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation.

Positives

• The acquisition reflects continued director alignment with company interests.
• The use of equity for compensation can conserve cash for the company.

Industry Context

Director share acquisitions are common in publicly traded companies as part of compensation packages to align the interests of directors with those of shareholders.

Related Party Transactions

• The issuance of shares to Linda M. Liau, a director, in lieu of cash compensation is a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance and conserves cash.

Key Dates